Engineered Bacteria for Cholera Prophylaxis

Karla J.F. Satchell*

*Corresponding author for this work

Research output: Contribution to journalShort surveypeer-review

Abstract

Over 1.3 billion persons are at risk for cholera globally. Vaccination campaigns are growing, but intervention options providing nearly immediate protection are also needed. Two recent papers in Science Translational Medicine describe probiotic bacteria that reduce intestinal colonization in animal models and show promise for development as prophylaxis agents. Over 1.3 billion persons are at risk for cholera globally. Vaccination campaigns are growing, but intervention options providing nearly immediate protection are also needed. Two recent papers in Science Translational Medicine describe probiotic bacteria that reduce intestinal colonization in animal models and show promise for development as prophylaxis agents.

Original languageEnglish (US)
Pages (from-to)192-194
Number of pages3
JournalCell Host and Microbe
Volume24
Issue number2
DOIs
StatePublished - Aug 8 2018

ASJC Scopus subject areas

  • Parasitology
  • Microbiology
  • Virology

Fingerprint Dive into the research topics of 'Engineered Bacteria for Cholera Prophylaxis'. Together they form a unique fingerprint.

Cite this